Concordix targets faster nutraceutical product launches through delivery science and integrated brand infrastructure

Editor’s Note: this article has been updated on February 17, 2026 at 2:10pm to include an AI disclosure.

Concordix announced its intent to innovate nutraceutical delivery with a suite of commercialization-focused updates designed to help brands accelerate product launches while maintaining scientific rigor. The platform’s latest developments center on launch-ready formulations, expanded intellectual property protection, and integrated marketing support intended to connect formulation science with real-world market success, a February 11 press release from Concordix explains.¹ Contract development and manufacturing organization Vitux AS, the developer of Concordix, will be present at Natural Products Expo West 2026, taking place March 3-6 to further discuss these developments.

Technology details

The Concordix technology utilizes a patented chewable emulsion system engineered to enhance both bioavailability and the consumer experience. The format enables delivery of high-potency combinations of oil- and water-soluble actives while also improving palatability. As the press release notes, these capabilities remain challenging for conventional capsules, tablets, or gummies. The format also encourages earlier digestive engagement aligned with natural nutrient pathways.

In a previous article for Nutritional Outlook, Marc van Maris, senior vice president of marketing and sales for the U.S. market at Vitux, explained that Concordix was introduced over a decade ago, and commented on the benefits and practical application of the technology.^2,3 “From my perspective, the most difficult thing to do is to get someone to change a habit that is ingrained through years of repetition,” he stated. “We are mirroring the structure of food by creating billions of small, oily droplets in the ConCordix Smart Chews. These droplets increase the contact surface in the intestines and lead to a higher degree of absorption of ingredients when compared to softgels.”

To support faster speed to market, the Concordix portfolio now includes more than 60 launch-ready concept products spanning priority health categories such as longevity, immune support, children’s development, and general wellness. New vegan-friendly formulations complement established delivery designs, giving both emerging and established brands flexible entry points for innovation without extending development timelines. Custom formulation partnerships remain available for companies seeking differentiated positioning beyond the standardized concept portfolio.

Commercialization infrastructure

Beyond formulation, Concordix is emphasizing commercialization infrastructure as a critical success factor. Brand partners can access a structured marketing playbook and customizable consumer-facing launch assets intended to clarify messaging around delivery technology, efficacy, and product differentiation.

Intellectual property

Intellectual property protection remains another focal point, the press release also explains. A U.S. patent covering the Concordix delivery system has received an extension, a key development reinforcing long-term platform security for partner brands. Additionally, highlighting connections between innovation and science, ongoing investment in clinical substantiation supports continued bioavailability, delivery performance, and compatibility of the platform with emerging active ingredients.

“Brands today are under pressure to move faster while still delivering products that work and resonate with consumers,” stated Catherine Nardone, vice president of marketing for Concordix. “By combining a patented delivery platform, launch-ready innovation, and commercialization support, Concordix helps partners go to market with confidence—without compromising on science or experience.”

Company representatives will discuss these developments with industry stakeholders during Expo West, further explaining how Concordix’s expanded platform is a response to increasing demand for differentiated, evidence-backed supplement formats that can move efficiently from concept to consumer.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

1. Concordix. Concordix Accelerates Supplement Innovation with Launch-Ready Concepts, Commercialization Support & Expanded Patent Protection. February 11, 2026.
2. Blatman, J. Omega-3 fish and plant sources: Can plant-based omega-3s only grow at fish oil’s expense? October 31, 2023. https://www.nutritionaloutlook.com/view/omega-3-fish-and-plant-sources-can-plant-based-omega-3s-only-grow-at-fish-oil-s-expense (Accessed 2026-02-16).
3. Blatman, J. Stay in your lane: Novel delivery systems must comply with supplement regulations. November 23, 2022. https://www.nutritionaloutlook.com/view/stay-in-your-lane-novel-delivery-systems-must-comply-with-supplement-regulations (Accessed 2026-02-16).